List of Tables
    Table 1. Anesthesia Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anesthesia Drugs Market Trends
    Table 3. Anesthesia Drugs Market Drivers
    Table 4. Anesthesia Drugs Market Challenges
    Table 5. Anesthesia Drugs Market Restraints
    Table 6. Global Anesthesia Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anesthesia Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anesthesia Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anesthesia Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anesthesia Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anesthesia Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anesthesia Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anesthesia Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anesthesia Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anesthesia Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anesthesia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anesthesia Drugs as of 2021)
    Table 18. Top Players of Anesthesia Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anesthesia Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Anesthesia Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anesthesia Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anesthesia Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anesthesia Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anesthesia Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anesthesia Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anesthesia Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anesthesia Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anesthesia Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anesthesia Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anesthesia Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anesthesia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anesthesia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anesthesia Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anesthesia Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anesthesia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anesthesia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anesthesia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anesthesia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anesthesia Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anesthesia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Astrazeneca Corporation Information
    Table 43. Astrazeneca Description and Business Overview
    Table 44. Astrazeneca Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Astrazeneca Anesthesia Drugs Product
    Table 46. Astrazeneca Recent Development
    Table 47. Fresenius-Kabi Corporation Information
    Table 48. Fresenius-Kabi Description and Business Overview
    Table 49. Fresenius-Kabi Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Fresenius-Kabi Product
    Table 51. Fresenius-Kabi Recent Development
    Table 52. AbbVie Corporation Information
    Table 53. AbbVie Description and Business Overview
    Table 54. AbbVie Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. AbbVie Product
    Table 56. AbbVie Recent Development
    Table 57. Baxter Healthcare Corporation Information
    Table 58. Baxter Healthcare Description and Business Overview
    Table 59. Baxter Healthcare Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Baxter Healthcare Product
    Table 61. Baxter Healthcare Recent Development
    Table 62. B.Braun Corporation Information
    Table 63. B.Braun Description and Business Overview
    Table 64. B.Braun Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. B.Braun Product
    Table 66. B.Braun Recent Development
    Table 67. Maruishi Corporation Information
    Table 68. Maruishi Description and Business Overview
    Table 69. Maruishi Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Maruishi Product
    Table 71. Maruishi Recent Development
    Table 72. Piramal Corporation Information
    Table 73. Piramal Description and Business Overview
    Table 74. Piramal Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Piramal Product
    Table 76. Piramal Recent Development
    Table 77. Hikma Pharmaceuticals Corporation Information
    Table 78. Hikma Pharmaceuticals Description and Business Overview
    Table 79. Hikma Pharmaceuticals Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Hikma Pharmaceuticals Product
    Table 81. Hikma Pharmaceuticals Recent Development
    Table 82. Mylan Corporation Information
    Table 83. Mylan Description and Business Overview
    Table 84. Mylan Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Mylan Product
    Table 86. Mylan Recent Development
    Table 87. Nhwa Corporation Information
    Table 88. Nhwa Description and Business Overview
    Table 89. Nhwa Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Nhwa Product
    Table 91. Nhwa Recent Development
    Table 92. Hengrui Corporation Information
    Table 93. Hengrui Description and Business Overview
    Table 94. Hengrui Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Hengrui Product
    Table 96. Hengrui Recent Development
    Table 97. Lunan Corporation Information
    Table 98. Lunan Description and Business Overview
    Table 99. Lunan Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Lunan Product
    Table 101. Lunan Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Anesthesia Drugs Customers List
    Table 105. Anesthesia Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anesthesia Drugs Product Picture
    Figure 2. Global Anesthesia Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anesthesia Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anesthesia Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Anesthesia Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anesthesia Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anesthesia Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Anesthesia Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anesthesia Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anesthesia Drugs Report Years Considered
    Figure 11. Product Picture of Propofol
    Figure 12. Product Picture of Etomidate
    Figure 13. Product Picture of Midazolam
    Figure 14. Product Picture of Sevoflurane
    Figure 15. Product Picture of Isoflurane
    Figure 16. Global Anesthesia Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Anesthesia Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Anesthesia Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Anesthesia Drugs Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Anesthesia Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Anesthesia Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Anesthesia Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Anesthesia Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Anesthesia Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Anesthesia Drugs Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Anesthesia Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Anesthesia Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Intravenous Anesthetics
    Figure 29. Product Picture of Inhalational Anesthetics
    Figure 30. Global Anesthesia Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Anesthesia Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Anesthesia Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Anesthesia Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Anesthesia Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Anesthesia Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Anesthesia Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Anesthesia Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Anesthesia Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Anesthesia Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Anesthesia Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Anesthesia Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Anesthesia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Anesthesia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Anesthesia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Anesthesia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Anesthesia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Anesthesia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Anesthesia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Anesthesia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Anesthesia Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Anesthesia Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Anesthesia Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Anesthesia Drugs Value Chain
    Figure 76. Anesthesia Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed